• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

组蛋白去甲基化酶 JHDM2a 缺陷型小鼠的肥胖和代谢综合征。

Obesity and metabolic syndrome in histone demethylase JHDM2a-deficient mice.

机构信息

Metabolism and Endocrinology Division, Laboratory for Systems Biology and Medicine, Research Center for Advanced Science and Technology, University of Tokyo, Tokyo 153-8904, Japan.

出版信息

Genes Cells. 2009 Aug;14(8):991-1001. doi: 10.1111/j.1365-2443.2009.01326.x. Epub 2009 Jul 15.

DOI:10.1111/j.1365-2443.2009.01326.x
PMID:19624751
Abstract

Histone H3 lysine 9 (H3K9) methylation is a crucial epigenetic mark of heterochromatin formation and transcriptional silencing. Recent studies demonstrated that most covalent histone lysine modifications are reversible and the jumonji C (JmjC)-domain-containing proteins have been shown to possess such demethylase activities. However, there is little information available on the biological roles of histone lysine demethylation in intact animal model systems. JHDM2A (JmjC-domain-containing histone demethylase 2A, also known as JMJD1A) catalyses removal of H3K9 mono- and dimethylation through iron and alpha-ketoglutarate dependent oxidative reactions. Here, we demonstrate that JHDM2a also regulates metabolic genes related to energy homeostasis including anti-adipogenesis, regulation of fat storage, glucose transport and type 2 diabetes. Mice deficient in JHDM2a (JHDM2a-/-) develop adult onset obesity, hypertriglyceridemia, hypercholesterolemia, hyperinsulinemia and hyperleptinemia, which are hallmarks of metabolic syndrome. JHDM2a-/- mice furthermore exhibit fasted induced hypothermia indicating reduced energy expenditure and also have a higher respiratory quotient indicating less fat utilization for energy production. These observations may explain the obesity phenotype in these mice. Thus, H3K9 demethylase JHDM2a is a crucial regulator of genes involved in energy expenditure and fat storage, which suggests it is a previously unrecognized key regulator of obesity and metabolic syndrome.

摘要

组蛋白 H3 赖氨酸 9(H3K9)甲基化是异染色质形成和转录沉默的关键表观遗传标记。最近的研究表明,大多数共价组蛋白赖氨酸修饰是可逆的,并且含有 JmjC 结构域的蛋白质已被证明具有这种去甲基化酶活性。然而,在完整的动物模型系统中,关于组蛋白赖氨酸去甲基化的生物学作用的信息很少。JHDM2A(含有 JmjC 结构域的组蛋白去甲基酶 2A,也称为 JMJD1A)通过铁和α-酮戊二酸依赖性氧化反应催化 H3K9 单甲基化和二甲基化的去除。在这里,我们证明 JHDM2a 还调节与能量稳态相关的代谢基因,包括抗脂肪生成、脂肪储存调节、葡萄糖转运和 2 型糖尿病。缺乏 JHDM2a 的小鼠(JHDM2a-/-)会发展出成年起病的肥胖、高甘油三酯血症、高胆固醇血症、高胰岛素血症和高瘦素血症,这些都是代谢综合征的标志。JHDM2a-/-小鼠还表现出禁食诱导的体温过低,表明能量消耗减少,呼吸商也更高,表明脂肪利用减少用于能量产生。这些观察结果可以解释这些小鼠的肥胖表型。因此,H3K9 去甲基酶 JHDM2a 是参与能量消耗和脂肪储存的基因的关键调节剂,这表明它是肥胖和代谢综合征的一个以前未被认识的关键调节剂。

相似文献

1
Obesity and metabolic syndrome in histone demethylase JHDM2a-deficient mice.组蛋白去甲基化酶 JHDM2a 缺陷型小鼠的肥胖和代谢综合征。
Genes Cells. 2009 Aug;14(8):991-1001. doi: 10.1111/j.1365-2443.2009.01326.x. Epub 2009 Jul 15.
2
Histone demethylase JHDM2A is critical for Tnp1 and Prm1 transcription and spermatogenesis.组蛋白去甲基化酶JHDM2A对Tnp1和Prm1转录以及精子发生至关重要。
Nature. 2007 Nov 1;450(7166):119-23. doi: 10.1038/nature06236. Epub 2007 Oct 17.
3
Role of Jhdm2a in regulating metabolic gene expression and obesity resistance.Jhdm2a在调节代谢基因表达和抗肥胖中的作用。
Nature. 2009 Apr 9;458(7239):757-61. doi: 10.1038/nature07777. Epub 2009 Feb 4.
4
Histone demethylase JHDM2A is involved in male infertility and obesity.组蛋白去甲基化酶JHDM2A与男性不育症和肥胖症有关。
J Androl. 2010 Jan-Feb;31(1):75-8. doi: 10.2164/jandrol.109.008052. Epub 2009 Oct 29.
5
JHDM2A, a JmjC-containing H3K9 demethylase, facilitates transcription activation by androgen receptor.JHDM2A是一种含JmjC结构域的H3K9去甲基化酶,可促进雄激素受体介导的转录激活。
Cell. 2006 May 5;125(3):483-95. doi: 10.1016/j.cell.2006.03.027. Epub 2006 Apr 6.
6
Rescuing the aberrant sex development of H3K9 demethylase Jmjd1a-deficient mice by modulating H3K9 methylation balance.通过调节H3K9甲基化平衡挽救H3K9去甲基化酶Jmjd1a缺陷小鼠的异常性发育。
PLoS Genet. 2017 Sep 26;13(9):e1007034. doi: 10.1371/journal.pgen.1007034. eCollection 2017 Sep.
7
Histone demethylase JHDM2A regulates H3K9 dimethylation in response to arsenic-induced DNA damage and repair in normal human liver cells.组蛋白去甲基酶 JHDM2A 调节 H3K9 二甲基化,以响应砷诱导的正常人类肝细胞中的 DNA 损伤和修复。
J Appl Toxicol. 2020 Dec;40(12):1661-1672. doi: 10.1002/jat.4026. Epub 2020 Jul 1.
8
Identification of JmjC domain-containing UTX and JMJD3 as histone H3 lysine 27 demethylases.鉴定含JmjC结构域的UTX和JMJD3为组蛋白H3赖氨酸27去甲基化酶。
Proc Natl Acad Sci U S A. 2007 Nov 20;104(47):18439-44. doi: 10.1073/pnas.0707292104. Epub 2007 Nov 14.
9
Nfat1 regulates adult articular chondrocyte function through its age-dependent expression mediated by epigenetic histone methylation.NFAT1 通过其受表观遗传组蛋白甲基化调控的年龄依赖性表达来调节成年关节软骨细胞的功能。
J Bone Miner Res. 2011 Aug;26(8):1974-86. doi: 10.1002/jbmr.397.
10
Control of histone H3 lysine 9 (H3K9) methylation state via cooperative two-step demethylation by Jumonji domain containing 1A (JMJD1A) homodimer.通过含有 Jumonji 结构域的 1A(JMJD1A)同源二聚体的两步协同去甲基化来控制组蛋白 H3 赖氨酸 9(H3K9)的甲基化状态。
J Biol Chem. 2013 Dec 27;288(52):36948-56. doi: 10.1074/jbc.M113.492595. Epub 2013 Nov 8.

引用本文的文献

1
Post-translational modifications in the pathophysiological process of metabolic dysfunction‑associated steatotic liver disease.代谢功能障碍相关脂肪性肝病病理生理过程中的翻译后修饰
Cell Biosci. 2025 Jun 5;15(1):79. doi: 10.1186/s13578-025-01411-z.
2
Unraveling the relationship between histone methylation and nonalcoholic fatty liver disease.解析组蛋白甲基化与非酒精性脂肪性肝病之间的关系。
World J Hepatol. 2024 May 27;16(5):703-715. doi: 10.4254/wjh.v16.i5.703.
3
Mitochondrial biogenesis in white adipose tissue mediated by JMJD1A-PGC-1 axis limits age-related metabolic disease.
由JMJD1A-PGC-1轴介导的白色脂肪组织中的线粒体生物发生限制了与年龄相关的代谢疾病。
iScience. 2024 Mar 1;27(4):109398. doi: 10.1016/j.isci.2024.109398. eCollection 2024 Apr 19.
4
Histone Demethylase KDM3 (JMJD1) in Transcriptional Regulation and Cancer Progression.组蛋白去甲基化酶 KDM3(JMJD1)在转录调控和癌症进展中的作用。
Adv Exp Med Biol. 2023;1433:69-86. doi: 10.1007/978-3-031-38176-8_4.
5
Mechanism and recent updates on insulin-related disorders.胰岛素相关疾病的机制及最新进展
World J Clin Cases. 2023 Sep 6;11(25):5840-5856. doi: 10.12998/wjcc.v11.i25.5840.
6
Molecular and cellular regulation of thermogenic fat.生热脂肪的分子与细胞调控
Front Endocrinol (Lausanne). 2023 Jul 3;14:1215772. doi: 10.3389/fendo.2023.1215772. eCollection 2023.
7
Identification of ecdysone receptor target genes in the worker honey bee brains during foraging behavior.在工蜂觅食行为期间鉴定脑内蜕皮激素受体靶基因。
Sci Rep. 2023 Jun 28;13(1):10491. doi: 10.1038/s41598-023-37001-7.
8
Epitranscriptomics in metabolic disease.代谢性疾病中的表观转录组学。
Nat Metab. 2023 Mar;5(3):370-384. doi: 10.1038/s42255-023-00764-4. Epub 2023 Mar 23.
9
PPARα in the Epigenetic Driver Seat of NAFLD: New Therapeutic Opportunities for Epigenetic Drugs?PPARα在非酒精性脂肪性肝病的表观遗传驱动位置:表观遗传药物的新治疗机会?
Biomedicines. 2022 Nov 25;10(12):3041. doi: 10.3390/biomedicines10123041.
10
MYPT1-PP1β phosphatase negatively regulates both chromatin landscape and co-activator recruitment for beige adipogenesis.肌球蛋白轻链磷酸酶 1-PP1β 磷酸酶负调控米色脂肪生成的染色质景观和辅激活因子募集。
Nat Commun. 2022 Sep 29;13(1):5715. doi: 10.1038/s41467-022-33363-0.